Table 3.
Comparison of incidence of adverse reactions between the two groups [n (%)]
| Groups | Oral mucosal reaction | Skin reaction | Nausea and vomiting | Leukocyte decline | Total incidence |
|---|---|---|---|---|---|
| Control group (n=28) | 3 (10.71) | 2 (7.15) | 3 (10.71) | 3 (10.71) | 11 (39.28) |
| Research group (n=30) | 1 (3.33) | 2 (6.67) | 1 (3.33) | 0 (0.00) | 4 (13.33) |
| χ2 | - | - | - | 5.087 | |
| P | - | - | - | 0.024 |